샘플 요청 목록

 카트 문의
시장보고서
상품코드
1513887

세계의 인슐린 전달 시스템 시장

Insulin Delivery Systems
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 272 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

인슐린 전달 시스템 세계 시장 규모는 2030년까지 168억 달러에 달할 전망

2023년 134억 달러로 추정되는 인슐린 전달 시스템 세계 시장은 2023-2030년 분석 기간 동안 연평균 3.3% 성장하여 2030년에는 168억 달러에 달할 것으로 예상됩니다. 이 보고서에서 분석하는 부문 중 하나인 주사기는 CAGR 3.4%를 기록하여 분석 기간 종료 시점에 70억 달러에 도달할 것으로 예상됩니다. 펜 부문의 성장률은 분석 기간 동안 CAGR 4.3%로 추정됩니다.

미국 시장 36억 달러로 추정, 중국은 CAGR 5.8%로 성장 전망

미국 인슐린 전달 시스템 시장은 2023년 36억 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 34억 달러의 시장 규모에 도달할 것으로 예상되며, 2023-2030년 분석 기간 동안 5.8%의 CAGR을 기록할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 0.6%와 4.0%의 CAGR을 기록할 것으로 예상됩니다. 유럽에서는 독일이 연평균 1.4%의 성장률을 보일 것으로 예상됩니다.

인슐린 전달 시스템 - 주요 동향 및 촉진요인

인슐린 전달 시스템은 전 세계 수백만 명이 앓고 있는 만성 질환인 당뇨병을 관리하는 데 필수적인 요소입니다. 인슐린 전달 시스템은 혈당 조절에 필요한 호르몬인 인슐린을 제어되고 효율적인 방식으로 투여하도록 설계되었습니다. 인슐린 전달 시스템에는 주사기, 인슐린 펜, 인슐린 펌프, 흡입형 인슐린과 같은 새로운 방법 등 다양한 종류가 있습니다. 각 시스템은 편의성, 정확성, 사용자 경험 측면에서 서로 다른 장점을 가지고 있습니다. 예를 들어, 인슐린 펜은 미리 채워져 있고 휴대가 간편하기 때문에 많은 환자들에게 인기 있는 선택이 되고 있습니다. 인슐린 펌프는 체내 자연 인슐린 분비에 가까운 지속적인 인슐린 분비가 가능하여 특히 제 1 형 당뇨병 환자에게 유익합니다. 의료 기술의 발전과 환자의 요구에 대한 깊은 이해로 인해 상황은 끊임없이 진화하고 있습니다.

기술 혁신은 인슐린 전달 시스템의 발전에 큰 원동력이 되고 있습니다. 최신 인슐린 펌프는 지속적 혈당 모니터링(CGM) 통합, 자동 인슐린 투여(AID), 스마트폰 연결과 같은 첨단 기능을 갖추고 있습니다. 이러한 발전은 보다 정확하고 개인화된 당뇨병 관리를 가능하게 하여 저혈당 위험을 줄이고 전반적인 혈당 조절을 개선할 수 있습니다. 또한, 복용량을 추적하고 알림을 제공할 수 있는 스마트 인슐린 펜의 개발은 복약 순응도 및 투약 정확도 문제를 해결하는 데 도움이 되고 있습니다. 흡입형 인슐린은 주사 대신 비침습적 대안을 제공함으로써 주사바늘을 싫어하는 환자들에게 어필하고 있습니다. 또한, 인공 췌장 시스템이라고도 불리는 폐쇄형 루프 시스템에 대한 연구도 진행 중이며, 환자의 개입을 최소화하는 완전 자동 인슐린 투여 솔루션을 구현하는 것을 목표로 하고 있습니다. 이러한 기술 혁신은 당뇨병 환자의 삶의 질을 향상시킬 뿐만 아니라 당뇨병 치료의 새로운 표준이 되고 있습니다.

인슐린 전달 시스템 시장의 성장은 당뇨병 유병률 증가, 기술 발전, 당뇨병 관리에 대한 인식 증가 등 여러 가지 요인에 의해 주도되고 있습니다. 비만과 좌식 생활습관 등의 요인으로 인해 당뇨병, 특히 제 2형 당뇨병의 유병률이 증가함에 따라 효율적이고 사용하기 쉬운 인슐린 전달 솔루션에 대한 수요가 크게 증가하고 있습니다. 기술의 발전으로 인해 이러한 시스템은 더욱 쉽고 효과적으로 사용할 수 있게 되어 더 많은 환자들을 끌어들이고 있습니다. 모바일 앱과 클라우드 기반 데이터 관리와 같은 디지털 헬스 기술의 통합은 환자의 참여와 치료 프로토콜 준수를 강화하고 있습니다. 소비자 행동도 변화하고 있으며, 편의성과 최소침습성 옵션에 대한 선호도가 높아지면서 스마트 펜이나 흡입형 인슐린과 같은 혁신적인 전달 방법의 채택을 촉진하고 있습니다. 또한, 당뇨병 치료 인프라 구축을 위한 정부 지원 정책 및 이니셔티브가 시장 성장을 촉진하고 있습니다. 경쟁 환경은 하이테크 기업과 의료 서비스 제공자의 협업이 두드러지게 나타나고 있으며, 이는 혁신과 시장 침투를 더욱 가속화하고 있습니다. 전반적으로, 인슐린 전달 시스템 시장은 인구 동향, 기술 발전, 진화하는 환자 선호도의 조합에 힘입어 크게 확대될 것으로 예상됩니다.

조사 대상 기업 예시(총 32개사)

  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Insulet Corporation
  • Medtronic, Inc.
  • Novo Nordisk A/S
  • Wockhardt Ltd.
  • Ypsomed AG

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 24.07.24

Global Insulin Delivery Systems Market to Reach US$16.8 Billion by 2030

The global market for Insulin Delivery Systems estimated at US$13.4 Billion in the year 2023, is expected to reach US$16.8 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2023-2030. Syringes, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$7.0 Billion by the end of the analysis period. Growth in the Pens segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.6 Billion While China is Forecast to Grow at 5.8% CAGR

The Insulin Delivery Systems market in the U.S. is estimated at US$3.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2030 trailing a CAGR of 5.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.6% and 4.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.4% CAGR.

Insulin Delivery Systems - Key Trends and Drivers

Insulin delivery systems are a critical component in the management of diabetes, a chronic condition affecting millions of people worldwide. These systems are designed to administer insulin, a hormone necessary for regulating blood glucose levels, in a controlled and efficient manner. There are various types of insulin delivery systems, including syringes, insulin pens, insulin pumps, and newer methods like inhalable insulin. Each of these systems offers different advantages in terms of convenience, precision, and user experience. Insulin pens, for example, are prefilled and easy to carry, making them a popular choice for many patients. Insulin pumps provide continuous insulin delivery, closely mimicking the body’s natural insulin release, which is particularly beneficial for individuals with type 1 diabetes. The landscape of insulin delivery systems is continuously evolving, driven by advancements in medical technology and a deeper understanding of patient needs.

Technological innovation has been a significant driver in the advancement of insulin delivery systems. Modern insulin pumps are now equipped with advanced features such as continuous glucose monitoring (CGM) integration, automated insulin delivery (AID), and smartphone connectivity. These advancements allow for more precise and personalized diabetes management, reducing the risk of hypoglycemia and improving overall glycemic control. Additionally, the development of smart insulin pens, which can track doses and provide reminders, is helping to address issues related to adherence and dosing accuracy. The introduction of inhalable insulin offers a non-invasive alternative to injections, appealing to patients who are needle-averse. Furthermore, research into closed-loop systems, also known as artificial pancreas systems, is ongoing, with the goal of creating fully automated insulin delivery solutions that require minimal patient intervention. These innovations are not only improving the quality of life for diabetes patients but are also setting new standards in diabetes care.

The growth in the insulin delivery systems market is driven by several factors, including the increasing prevalence of diabetes, technological advancements, and a growing awareness of diabetes management. The rising incidence of diabetes particularly type 2 diabetes, due to factors such as obesity and sedentary lifestyles, has significantly expanded the demand for efficient and user-friendly insulin delivery solutions. Technological advancements have made these systems more accessible and effective, attracting a broader patient base. The integration of digital health technologies, such as mobile apps and cloud-based data management, is enhancing patient engagement and adherence to treatment protocols. Consumer behavior is also shifting, with a greater emphasis on convenience and minimally invasive options, driving the adoption of innovative delivery methods like smart pens and inhalable insulin. Additionally, supportive government policies and initiatives aimed at improving diabetes care infrastructure are facilitating market growth. The competitive landscape is marked by collaborations between tech companies and healthcare providers, further accelerating innovation and market penetration. Overall, the insulin delivery systems market is poised for significant expansion, propelled by a combination of demographic trends, technological progress, and evolving patient preferences.

Select Competitors (Total 32 Featured) -

  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Insulet Corporation
  • Medtronic, Inc.
  • Novo Nordisk A/S
  • Wockhardt Ltd.
  • Ypsomed AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Insulin Delivery Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Diabetes Throws the Spotlight on Insulin Delivery Systems
    • Technological Advancements Propel Growth in Smart Insulin Delivery Devices
    • Increasing Adoption of Continuous Glucose Monitoring (CGM) Systems Expands Addressable Market Opportunity
    • Integration of Digital Health Technologies Strengthens Business Case for Advanced Insulin Delivery Solutions
    • Development of Automated Insulin Delivery (AID) Systems Boost Innovation
    • Non-Invasive Delivery Methods, Such as Inhalable Insulin, Drive Adoption among Needle-Averse Patients
    • Enhanced Smartphone Connectivity and Mobile App Integration Spurs Growth in User Engagement
    • Personalized Diabetes Management Generates Demand for Customized Insulin Delivery Solutions
    • Research into Closed-Loop Systems and Artificial Pancreas Technology Throws the Spotlight on Future Trends
    • Increased Focus on Minimally Invasive Options Expands Addressable Market Opportunity
    • Consumer Shift towards Convenience and Ease of Use Drives Adoption of Innovative Insulin Delivery Methods
    • Enhanced Data Management and Cloud-Based Solutions Generates Demand for Integrated Insulin Delivery Systems
    • Rising Incidence of Type 2 Diabetes among Younger Populations Influences Market Dynamics
    • Improving Quality of Life for Diabetes Patients Sustains Growth in Advanced Insulin Delivery Technologies
    • Evolution of Smart Insulin Pens and Dose Tracking Technologies Strengthens Business Case for Precision Medicine
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Insulin Delivery Systems Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Insulin Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Insulin Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Insulin Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Pens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Pen needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Pen needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Pen needles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Jet Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Homecare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Homecare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Homecare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Ambulatory Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Ambulatory Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Ambulatory Care Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Insulin Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Insulin Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Insulin Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Insulin Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Insulin Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Australia 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • INDIA
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: India 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: South Korea 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Insulin Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Insulin Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Insulin Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Latin America 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Argentina 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Brazil 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Mexico 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Rest of Latin America 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Insulin Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Insulin Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Insulin Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Middle East 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Iran 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Israel 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Saudi Arabia 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: UAE 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Rest of Middle East 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030
  • AFRICA
    • Insulin Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Insulin Delivery Systems by Product - Syringes, Pens, Pen needles, Pumps and Jet Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Insulin Delivery Systems by Product - Percentage Breakdown of Value Sales for Syringes, Pens, Pen needles, Pumps and Jet Injectors for the Years 2014, 2024 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Insulin Delivery Systems by End-Use - Homecare, Hospitals, Clinics and Ambulatory Care Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Africa 16-Year Perspective for Insulin Delivery Systems by End-Use - Percentage Breakdown of Value Sales for Homecare, Hospitals, Clinics and Ambulatory Care Centers for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제